Nanotechnological Advancements in Diabetes Management: Unravelling the Therapeutic Efficacy of Phytosomes.

Abstract

Introduction: Diabetes, a widespread condition, wreaks havoc on the body's systems over time, particularly affecting nerves and blood vessels, leading to a weakened immune system. According to data from the International Diabetes Federation (IDF), the top three countries with the highest number of diabetics in 2019 were China (116.4 million), India (77.0 million), and the United States (31 million). This article explores the pivotal role of phytosomes, cutting-edge nanotechnology, in addressing diabetes mellitus. This review aims to investigate the therapeutic potential of phytosomes, a novel nanotechnology, in managing diabetes mellitus and addressing its associated physiological challenges.

Method: A thorough literature review was performed, encompassing research papers, clinical studies, and relevant data on diabetes and phytosomes. The focus is on understanding phytosomes' benefits and the complexities involved in diabetes management.

Result: Phytosomes have emerged as a game-changer in diabetes mellitus, offering superior efficacy compared to traditional dosage forms. Their unique properties, including small particle size, enhanced cellular uptake, low cytotoxicity, potent anti-inflammatory, antibacterial, and antioxidant activities, as well as excellent biocompatibility and biodegradability, position them as a promising therapeutic approach.

Discussion: Phytosomes significantly enhanced the bioavailability and therapeutic efficacy of plant-based compounds, thereby mitigating oxidative stress, inflammation, and insulin resistance.

Conclusion: By leveraging the advanced capabilities of phytosomes, healthcare practitioners can potentially overcome the challenges associated with diabetes, paving the way for improved patient outcomes and enhanced public health.